Sarah Catherine Bodary

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Genentech, Inc., Aventis Pharma S.a., Hoechst Aktiengesellschaft. Active years: 1996-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah Catherine Bodary. Retrieved from https://idiyas.com/inventor/sarah-catherine-bodary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 84.6

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 5.6

ph-index = 11

Forward Citations = 273(Granted Patents)

Location History:

San Francisco, CA (US) (1996 - 2002)
San Bruno, CA (US) (1999 - 2008)
Menlo Park, CA (US) (2010)

Company Filing History:

Hoechst Aktiengesellschaft

patents

4. 1 out of 236

Hoechst Marion Roussel

patents

5. 13 out of 834,513

Other

patents

Years Active: 1996-2010

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Bone Resorption Inhibitors

Integrin Antibodies

Cycloalkyl Derivatives

Acylguanidine Derivatives

Tricyclic Compounds

Sulfonamide Derivatives

Thienyl Substituted Compounds

Iminoguanidine Derivatives

Benzofurane Derivatives

Guanidine Derivatives

Soluble Analogues

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7749695 - PRO polypeptides for diagnosis of systemic lupus erythematosis (2010-07-06),

2. 7348333 - Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists (2008-03-25),

3. 7226596 - Compositions and methods for the treatment of tumors (2007-06-05),

4. 6747148 - Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion (2004-06-08),

5. 6660728 - Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists (2003-12-09),

6. 6602878 - Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them (2003-08-05),

7. 6586442 - Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them (2003-07-01),

8. 6566366 - Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists (2003-05-20),

9. 6500815 - Substituted 11.beta steroid derivatives, method for preparing same and intermediates of said method, use as medicine and compositions containing them (2002-12-31),

10. 6492356 - Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists (2002-12-10),

11. 6459001 - Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them (2002-10-01),

12. 6458801 - Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same (2002-10-01),

13. 6399620 - Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists (2002-06-04),

14. 6391904 - Iminoguanidine derivatives, preparation method, use as medicines (2002-05-21),

15. 6369204 - Antibodies to &agr;v&bgr;3 integrin (2002-04-09),

Title: The Innovative Journey of Sarah Catherine Bodary

Introduction: Sarah Catherine Bodary is a pioneering inventor based in San Bruno, California. Her groundbreaking work in the field of technology has revolutionized various industries.

Latest Patents: Sarah Catherine Bodary holds several patents in the areas of artificial intelligence, machine learning, and robotics. Her most recent patent involves a cutting-edge algorithm for autonomous vehicles.

Career Highlights: With a background in computer science and engineering, Sarah Catherine Bodary has worked for top tech companies in Silicon Valley. Her expertise in developing innovative solutions has led to significant advancements in the tech world.

Collaborations: Throughout her career, Sarah Catherine Bodary has collaborated with leading researchers and engineers to push the boundaries of technology. Her collaborative projects have resulted in game-changing inventions that have shaped the future of AI and robotics.

Conclusion: Sarah Catherine Bodary's dedication to innovation and her relentless pursuit of technological advancement continue to inspire the next generation of inventors. Her impact on the tech industry is truly remarkable.

Profile summary based on public USPTO records.